Fredun Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 167.41 | 102.70 | 107.35 |
| Operating Expense | 149.97 | 89.47 | 93.40 |
| Net Profit | 7.07 | 5.33 | 4.27 |
| Net Profit Margin | 4.22 | 5.19 | 3.98 |
| Earning Per Share | 14.98 | 11.29 | 9.05 |
| EBIDTA | 17.44 | 13.22 | 13.94 |
| Effective Tax Rate | 5.56 | 13.61 | 23.66 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 167.41 |
| Operating Expense | 149.97 |
| Net Profit | 7.07 |
| Net Profit Margin | 4.22 |
| Earning Per Share | 14.98 |
| EBIDTA | 17.44 |
| Effective Tax Rate | 5.56 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 348.16 | 274.68 | 224.46 |
| Operating Expenses Annual | 310.17 | 246.90 | 210.66 |
| Operating Profit Annual | 38.90 | 29.60 | 15.43 |
| Interest Annual | 13.65 | 9.28 | 4.67 |
| Depreciation | 3.80 | 2.81 | 2.16 |
| Net Profit Annual | 15.62 | 10.81 | 6.34 |
| Tax Annual | 5.83 | 6.70 | 2.26 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 348.16 |
| Operating Expenses Annual | 310.17 |
| Operating Profit Annual | 38.90 |
| Interest Annual | 13.65 |
| Depreciation | 3.80 |
| Net Profit Annual | 15.62 |
| Tax Annual | 5.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.44 | 2.07 | 1.13 |
| Cash Flow from Operations | -0.44 | -14.41 | -2.38 |
| Cash Flow from Investing | -7.64 | -9.40 | -4.14 |
| Cash Flow from Financing | 5.99 | 25.18 | 7.47 |
| Cash Flow at the End | 1.35 | 3.44 | 2.07 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.44 |
| Cash Flow from Operations | -0.44 |
| Cash Flow from Investing | -7.64 |
| Cash Flow from Financing | 5.99 |
| Cash Flow at the End | 1.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.17 | 10.78 | 6.91 |
| PBIT Margin (%) | 10.08 | 9.75 | 5.94 |
| PBT Margin (%) | 9.34 | 8.70 | 4.69 |
| Net PROFIT Margin (%) | 4.49 | 3.94 | 2.82 |
| Return On Networth / Equity (%) | 14.34 | 13.15 | 11.41 |
| Return On Networth /Employed (%) | 16.95 | 17.43 | 12.90 |
| Return On Assets (%) | 7.54 | 7.04 | 6.13 |
| Total Debt / Equity (X) | 0.88 | 0.85 | 0.83 |
| Asset Turnover Ratio (%) | 1.68 | 1.79 | 2.17 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.17 |
| PBIT Margin (%) | 10.08 |
| PBT Margin (%) | 9.34 |
| Net PROFIT Margin (%) | 4.49 |
| Return On Networth / Equity (%) | 14.34 |
| Return On Networth /Employed (%) | 16.95 |
| Return On Assets (%) | 7.54 |
| Total Debt / Equity (X) | 0.88 |
| Asset Turnover Ratio (%) | 1.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 46.57 | 38.93 | 32.34 |
| Total Current Assets Annual | 257.20 | 216.21 | 152.65 |
| Non Current Assets Annual | 50.40 | 41.07 | 34.34 |
| Total Shareholders Funds Annual | 121.47 | 96.38 | 68.06 |
| Total Assets Annual | 307.60 | 257.28 | 186.99 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 46.57 |
| Total Current Assets Annual | 257.20 |
| Non Current Assets Annual | 50.40 |
| Total Shareholders Funds Annual | 121.47 |
| Total Assets Annual | 307.60 |
EPS (INR)
Expected
12.71
Reported
12.71
Surprise
0.00%
